In a move poised to enhance its governance and support continued growth, Fidson Healthcare Plc, one of Nigeria’s leading pharmaceutical companies, has appointed three new directors to its board.
Fidson Healthcare Plc has reported a rise in its full-year revenue, reaching N84.19bn for the financial period ended December 31, 2024. This represents a 58.7 per cent increase compared to the N53 ...
Fidson Healthcare Plc, a top pharmaceutical company in Nigeria, has appointed three new directors in a move to bolster its team’s strategy. The decision was reached by the board in December, 2024, ...
Nigeria’s leading pharmaceutical company, Fidson Healthcare Plc announces the appointment of three new Directors. This strategic move, made by the Board, at a meeting held in December 2024, ...
Fidson的股票在拉各斯挂牌交易。 Fidson的股票代码是什么? Fidson的股票代码是“FIDSON。” Fidson有分红吗?当前的股息收益率是多少? Fidson的股息收益率是3.66%。 Fidson的市值是多少? 截至今天,Fidson的市值是35.92B。 Fidson的每股收益(EPS)是多少? Fidson的每股收益(EPS ...
Shares of Fidson Healthcare Plc rose by 24% in the first week of February 2025, with a trading volume of 8.8 million shares, securing a spot on the NGX’s advancers list for the week. The stock closed ...
Fidson Healthcare Plc, one of the leading pharmaceutical companies in the country, has announced the appointment of three new directors. The nomination of the directors namely; Babatunde Kabir Ipaye, ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Nigeria’s leading pharmaceutical company, Fidson Healthcare Plc has announced the appointment of three new directors. The appointments of the new directors, namely Dr Babatunde Kabir Ipaye, Mr Philip ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果